Full history for every metric is available with a Kvantra account

Stock profile

RIV Capital Inc. (RIV.CN)

Country: CanadaSector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: CNQ

Delisted · last close 19 Dec 2024

Current price
0.10 CAD-4.76%
Last close 19 Dec 2024
Benchmarks

Key financial summary

Financials in USD
201820192020202120222023TTM
Total revenue$m3810137710
Operating profit$m-18-84
Net profit$m3-29-106-42-179-80-77
EPS reported$-0.59-0.56
Operating cashflow per share$-0.09-0.09
Capex per share$0.040.03
FCF per share$-0.12-0.14
Free cash flow$m--24
Net debt$m-67
Book value equity$m--36
Book value per share$0.80-0.26
Number of sharesm135.68136.33
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
201820192020202120222023TTM
Value
P/E TTMx--
P/B LTMx0.13-0.27
P/S LTMx2.100.93
P/FCF LTMx-0.85-0.40
EV/EBITDA LTMx-2.49-0.78
EV/Sales LTMx6.367.38
Earnings Yield LTM%-564.23%-891.18%
FCF Yield%-117.83%-251.33%
Quality
ROE%-73.85%-112.58%
ROIC%-13.87%-34.21%
Operating margin%-269.92%-1519.7%
Gross margin%35.77%-3.07%
FCF/Sales%-246.61%-339.76%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%0.00%+42.77%
Net Income Growth YoY%--
FCF Growth%--
Operating Profit Growth%--
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx--0.18
Net Debt/EBITDAx-1.28-2.75
EBIT/Net interestx-1.660.00
Net debt/market cap%-696.70%
Net debt/Equityx--1.87
Gross debt/equityx--3.68

Company overview

RIV Capital Inc., formerly known as Canopy Rivers Inc., operates as a venture capital firm with a versatile investment approach. While open to opportunities across all company stages, from initial seed funding through commercialization, its primary focus is on Series A through C financing rounds. The firm's strategic interest is firmly rooted in the burgeoning cannabis sector, actively seeking out promising marijuana-related businesses and adjacent industries. Its comprehensive investment scope encompasses a wide array of areas: Agriculture and food sciences: Spanning plant, soil, food, animal, and environmental science. Production: Including diverse cultivation methods such as indoor, greenhouse, outdoor, and nursery, alongside fermentation. Processing: Involving harvesting, extraction, purification, packaging, food and beverage processing, and laboratory testing services. Pharmaceuticals and biotechnology: Covering drug discovery and development, various delivery methods (e.g., pills, soft gels, tinctures), biosynthetic derived cannabinoids, medical devices (e.g., inhalers), and lab equipment. Technology and consumer goods: Such as software and data, specialized hardware, consumer products and accessories (e.g., edibles, beverages, inhalables, cosmetics, cannabis consumption tools), and wellness products. Market access: Including retail and distribution channels (licensed brick-and-mortar stores, pharmacies, online marketplaces, delivery services), and media and content creation. Furthermore, specific product categories of interest include beverages, capsules, concentrates, edibles, dry flower/pre-rolls, vaporizers and associated hardware, pet products, and topicals. RIV Capital actively pursues investment prospects on a global scale. While check sizes have historically ranged from CA$1 million (approximately $0.71 million USD) to CA$40 million (around $28.45 million USD), the firm typically invests between CA$5 million (roughly $3.6 million USD) and CA$10 million (approximately $7.1 million USD). The firm generally seeks to acquire minority ownership stakes and employs a flexible array of investment instruments, including debt financing, preferred and common equity, and production-linked royalties. RIV Capital Inc. was established in 2017 and is headquartered in Toronto, Canada.

WebsiteN/A
IndustryDrug Manufacturers - Specialty & Generic
CountryCanada
Trades inCAD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 19 Dec 2024

RIV Capital Inc. (RIV.CN)

RIV.CN · CNQ · Healthcare
0.10 CAD-4.76%
Benchmarks
Financialsin USD
20222023TTM
About

RIV Capital Inc., formerly known as Canopy Rivers Inc., operates as a venture capital firm with a versatile investment approach. While open to opportunities across all company stages, from initial seed funding through commercialization, its primary focus is on Series A through C financing rounds. The firm's strategic interest is firmly rooted in the burgeoning cannabis sector, actively seeking out promising marijuana-related businesses and adjacent industries. Its comprehensive investment scope encompasses a wide array of areas: Agriculture and food sciences: Spanning plant, soil, food, animal, and environmental science. Production: Including diverse cultivation methods such as indoor, greenhouse, outdoor, and nursery, alongside fermentation. Processing: Involving harvesting, extraction, purification, packaging, food and beverage processing, and laboratory testing services. Pharmaceuticals and biotechnology: Covering drug discovery and development, various delivery methods (e.g., pills, soft gels, tinctures), biosynthetic derived cannabinoids, medical devices (e.g., inhalers), and lab equipment. Technology and consumer goods: Such as software and data, specialized hardware, consumer products and accessories (e.g., edibles, beverages, inhalables, cosmetics, cannabis consumption tools), and wellness products. Market access: Including retail and distribution channels (licensed brick-and-mortar stores, pharmacies, online marketplaces, delivery services), and media and content creation. Furthermore, specific product categories of interest include beverages, capsules, concentrates, edibles, dry flower/pre-rolls, vaporizers and associated hardware, pet products, and topicals. RIV Capital actively pursues investment prospects on a global scale. While check sizes have historically ranged from CA$1 million (approximately $0.71 million USD) to CA$40 million (around $28.45 million USD), the firm typically invests between CA$5 million (roughly $3.6 million USD) and CA$10 million (approximately $7.1 million USD). The firm generally seeks to acquire minority ownership stakes and employs a flexible array of investment instruments, including debt financing, preferred and common equity, and production-linked royalties. RIV Capital Inc. was established in 2017 and is headquartered in Toronto, Canada.

IndustryDrug Manufacturers - Specialty & Generic
CountryCanada
Trades inCAD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free